E
Mosaic ImmunoEngineering, Inc. CPMV
$0.98 $0.27839.60%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 3/14/2023Downgrade
Mosaic ImmunoEngineering Inc. (CPMV) was downgraded to E+ from D- on 3/14/2023 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from -$0.0212 to -$0.0738.
D
Sell 2/23/2023Upgraded
Mosaic ImmunoEngineering, Inc. (CPMV) was upgraded to D- from E+ on 02/23/2023.
E
Sell 2/8/2023Downgrade
Mosaic ImmunoEngineering Inc. (CPMV) was downgraded to E+ from D- on 2/8/2023 due to a decline in the solvency index.
D
Sell 6/8/2022Upgraded
Mosaic ImmunoEngineering Inc. (CPMV) was upgraded to D- from E+ on 6/8/2022 due to an increase in the total return index and volatility index.
E
Sell 5/12/2022Downgrade
Mosaic ImmunoEngineering Inc. (CPMV) was downgraded to E+ from D- on 5/12/2022 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 13.59% from -$167 to -$189.7.
D
Sell 5/5/2022Upgraded
Mosaic ImmunoEngineering Inc. (CPMV) was upgraded to D- from E+ on 5/5/2022 due to an increase in the volatility index.
E
Sell 4/20/2022Downgrade
Mosaic ImmunoEngineering Inc. (CPMV) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index.
D
Sell 1/27/2022Upgraded
Mosaic ImmunoEngineering Inc. (CPMV) was upgraded to D- from E+ on 1/27/2022 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.1451 to -$0.1186, EBIT increased 14.16% from -$961.1 to -$825, and operating cash flow increased 11.73% from -$189.2 to -$167.
E
Sell 8/5/2021Upgraded
Mosaic ImmunoEngineering Inc. (CPMV) was upgraded to E+ from E on 8/5/2021 due to an increase in the growth index, efficiency index and valuation index. Operating cash flow increased 10.39% from -$170.4 to -$152.7, earnings per share increased from -$0.1544 to -$0.14, and total capital increased 6.72% from -$955.1 to -$890.9.
E
Sell 5/25/2021Upgraded
Mosaic ImmunoEngineering Inc. (CPMV) was upgraded to E from E- on 5/25/2021 due to an increase in the solvency index.
E
Sell 12/31/2020None
Mosaic ImmunoEngineering, Inc. (CPMV) was downgraded to E- from U on 12/31/2020.
Weiss Ratings